Amgen Inc. buy Wells Fargo & Company
Start price
13.03.23
/
50%
€219.90
Target price
13.03.24
€247.40
Performance (%)
14.78%
End price
14.03.24
€252.40
Summary
This prediction ended on 14.03.24 with a price of €252.40. The prediction had a final performance of 14.78%. A total of €7.97 was paid as dividends for this prediction. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Amgen Inc. | -0.244% | -0.244% | 7.554% | 38.319% |
| iShares Core DAX® | -1,03 % | -9,17 % | -1,56 % | 49,94 % |
| iShares Nasdaq 100 | -1,95 % | -2,62 % | 11,25 % | 77,36 % |
| iShares Nikkei 225® | -0,42 % | -9,42 % | 24,93 % | 51,28 % |
| iShares S&P 500 | -1,20 % | -2,99 % | 7,52 % | 59,46 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $265.00 price target on the stock, down previously from $275.00.
Ratings data for AMGN provided by MarketBeat
In the thread Trading Amgen Inc.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten